Musculoskeletal Disorders
Conference Coverage
Biomarkers may help to predict persistent oligoarticular JIA
Analysis of a small group of samples revealed that the selected biomarkers more accurately predicted persistent disease than disease likely to...
News
FDA expands indication for spinal muscular atrophy drug
After 12 months of risdiplam treatment, the majority of presymptomatic infants with SMA reached key motor milestones.
Conference Coverage
Pfizer COVID vaccine performs well in youth with rheumatic diseases
Nearly all participants in the study showed complete seroconversion, in contrast to similar studies in adults.
Guidelines
Myositis guidelines aim to standardize adult and pediatric care
These are the first guidelines on how to manage adult and pediatric patients with idiopathic inflammatory myopathies (IIM).
Conference Coverage
Prior authorizations delay TNF inhibitors for children with JIA
Many patients newly diagnosed with juvenile idiopathic arthritis (JIA) at one academic center over a year had delays in care due to unnecessary...
From the Journals
Children with RMDs not at high risk for severe COVID-19, study finds
“Many parents and families with children who have RMDs have lived with great fear over the pandemic about whether or not their children are at an...
From the Journals
JIA disease activity, disability linked to social factors
For patients with polyarticular juvenile idiopathic arthritis, levels of disease activity and disability vary, depending on family income,...
Letters from Maine
Give patients can’ts but also can do’s
In my experience, too many physicians forget to include a generous list of “can do’s” in their visit closing discussions.
Conference Coverage
Virtual and in-person pediatric visits get similar family ratings
Satisfaction ratings for both virtual and office visits were consistently higher than 85% across all measured parameters.
Guidelines
New JIA guidelines emphasize earlier DMARD use
Advances in understanding and treating systemic JIA have led practitioners away from steroids and toward using conventional synthetic and biologic...
Feature
Eighteen-year study shows inconsistencies in treating, classifying JIA
A long-term study of children with juvenile idiopathic arthritis highlights an inconsistent classification system and hints about how they manage...